ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,954.50
1.59%
US Tech 100
20,332.80
1.61%
다우존스 지수
43,840.91
1.39%
Bitcoin
85,215.14
1.00%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Immutep Ltd (IMMP) 시세

Immutep Ltd

Immutep Ltd (IMMP)

NASDAQ
1.93
0.03
(1.58%)
마감 01 3월 6:00AM
15분 지연
1.935
0.005
(0.26%)
시간외 거래: 9:59AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
1.93
매수가
1.81
매도가
1.97
거래량
118,807
1.87 일간 변동폭 1.94
0.00 52주 범위 0.00
market_cap
280.732M
전일 종가
1.90
개장가
1.87
최근 거래 시간
3
@
2
마지막 거래 시간
재정 규모
US$ 226,318
VWAP
1.9049
평균 볼륨(3m)
-
발행 주식
145,456,785
배당수익률
-
주가수익률
-1.02
주당순이익(EPS)
-0.29
매출
-
순이익
-42.72M

Immutep Ltd 정보

Immutep Ltd. is a clinical stage biotechnology company developing novel LAG-3 immunotherapy for cancer and autoimmune disease. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesse... Immutep Ltd. is a clinical stage biotechnology company developing novel LAG-3 immunotherapy for cancer and autoimmune disease. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesses LAG-3's unique ability to stimulate or suppress the immune response. Immutep's lead clinical candidate, eftilagimod alpha ('efti'), is a soluble LAG-3 protein and first-in-class MHC Class II agonist that stimulates both innate and adaptive immunity to fight cancer. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.immutep.com
본부
Sydney, New South Wales, Aus
설립됨
-
Immutep Ltd is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker IMMP. The last closing price for Immutep was US$1.90. Over the last year, Immutep shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Immutep currently has 145,456,785 shares in issue. The market capitalisation of Immutep is US$276.37 million. Immutep has a price to earnings ratio (PE ratio) of -1.02.

IMMP 최신 뉴스

추가 뉴스

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
27 2월 2025
IMMP (1.58%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
03 2월 2025
IMMP (1.58%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
13 12월 2024
IMMP (1.58%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
11 12월 2024
IMMP (1.58%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

IMMP - Frequently Asked Questions (FAQ)

What is the current Immutep share price?
The current share price of Immutep is US$ 1.93
How many Immutep shares are in issue?
Immutep has 145,456,785 shares in issue
What is the market cap of Immutep?
The market capitalisation of Immutep is USD 276.37M
What is the 1 year trading range for Immutep share price?
Immutep has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Immutep?
The price to earnings ratio of Immutep is -1.02
What is the reporting currency for Immutep?
Immutep reports financial results in AUD
What is the latest annual profit for Immutep?
The latest annual profit of Immutep is AUD -42.72M
What is the registered address of Immutep?
The registered address for Immutep is LEVEL 12, 95 PITT STREET, SYDNEY, NEW SOUTH WALES, 2000
What is the Immutep website address?
The website address for Immutep is www.immutep.com
Which industry sector does Immutep operate in?
Immutep operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
STAKSTAK Inc
US$ 3.97
(156.13%)
174.23k
ORGOOrganogenesis Holdings Inc
US$ 6.21
(102.28%)
59M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
193.57M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
137.18M
ARBBARB IOT Group Ltd
US$ 0.6635
(38.23%)
59.08M
NVNINVNI Group Ltd
US$ 0.99
(-50.50%)
72.79M
SPGCSacks Parente Golf Inc
US$ 0.2085
(-48.65%)
58.21M
ADGMAdagio Medical Holdings Inc
US$ 0.8081
(-47.53%)
756.76k
PRAXPraxis Precision Medicines Inc
US$ 38.60
(-40.64%)
3.2M
SAGSAG Holdings Ltd
US$ 1.19
(-38.97%)
789.86k
NVDANVIDIA Corporation
US$ 124.92
(3.97%)
389.48M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
193.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13.44
(7.78%)
154.46M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
137.18M
LCIDLucid Group Inc
US$ 2.22
(-0.45%)
136.17M

IMMP Discussion

게시물 보기
Monksdream Monksdream 6 월 전
IMMP 10 day hourly
👍️0
Monksdream Monksdream 7 월 전
IMMP under $2
👍️0
Vector2112 Vector2112 7 월 전
Refinitiv Logo
As of 06/27/2024

SellUnderperformHoldOutperformSelected Value:Buy
Refinitiv Stock Reports Plus
Refinitiv maintains a current price target of $8.64 for IMMP.
👍️0
glenn1919 glenn1919 8 월 전
IMMP......................https://stockcharts.com/h-sc/ui?s=IMMP&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 8 월 전
IMMP under $2
👍️0
Monksdream Monksdream 10 월 전
IMMP under $3
👍️0
Monksdream Monksdream 1 년 전
IMMP under $2
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
strong
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
ready
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
strong
👍️0
The Night Stalker The Night Stalker 2 년 전
watching
👍️0
The Night Stalker The Night Stalker 2 년 전
watching
👍️0
The Night Stalker The Night Stalker 2 년 전
dip
👍️0
The Night Stalker The Night Stalker 2 년 전
dip
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
im in my bio DRMA, one at a time


RIGL rip for more
👍️0
The Night Stalker The Night Stalker 2 년 전
beast
👍️0
DewDiligence DewDiligence 2 년 전
IMMP +65% on interim (single-arm) phase-2 data for LAG-3 drug with Keytruda in NSCLC:

https://finance.yahoo.com/news/immutep-efti-combination-pembrolizumab-achieves-120000596.html

IMMP’s eftilagimod alpha is a LAG-3 protein that targets the same biologic pathway as BMY’s relatlimab, one of the component drugs (along with Opdivo) in Opdulag.

BMY’s Opdulag, which was FDA approved in Mar 2022 for first-line melanoma, is already selling at an annualized rate of $500M in the US alone (#msg-171784010).

Please see #msg-168259768 for related info.
👍️0
Invest-in-America Invest-in-America 2 년 전
IMMP: Very likely the hands-down WINNER of this Wall Street day, Peeps!!! (Just when ya thought that CANCER was no longer TRENDING.)

👍️0
stocks2watch stocks2watch 3 년 전
Going to move up
👍️0
make it happen make it happen 4 년 전
It's cool covered most average was $3.68
👍️0
calahan67 calahan67 4 년 전
I think you're not taking into account whats in the pipeline mainly several studies involving much larger pharmaceutical interested the immune boosting properties of eftaligamod. Imo this company and ceo are the real deal. Forget the outlays and remember its research and development that costs the most up front no matter what pharm you're talking about
👍️0
make it happen make it happen 4 년 전
More debt than revenue, large negatives on everything (cash flow, returns and profit margins.

Profitability
Profit Margin 0.00%
Operating Margin (ttm) -300.79%

Management Effectiveness
Return on Assets (ttm) -20.00%
Return on Equity (ttm) -61.68%

Income Statement
Revenue (ttm) 6.35M
Revenue Per Share (ttm) 0.14
Quarterly Revenue Growth (yoy) -76.90%
Gross Profit (ttm) -6.66M
EBITDA -17.07M
Net Income Avi to Common (ttm) -27.36M
Diluted EPS (ttm) -0.4500

Total Debt (mrq) 9.75M
Book Value Per Share (mrq) 0.94

Cash Flow Statement
Operating Cash Flow (ttm) -14.67M
Levered Free Cash Flow (ttm) -7.67M
👍️0
sgunderbarth sgunderbarth 4 년 전
IMMP Interesting action....
👍️0
ClayTrader ClayTrader 4 년 전
* * $IMMP Video Chart 04-08-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
make it happen make it happen 4 년 전
Any positives in the numbers? Decent news but will need to raise money to keep anything going imho

IMMP is "ELIGIBLE" to receive development based milestones and sales based royalties. They do not have sales and drug is not out.


Profitability
Profit Margin 0.00%
Operating Margin (ttm) -300.79%

Management Effectiveness
Return on Assets (ttm) -20.00%
Return on Equity (ttm) -61.68%

Income Statement
Revenue (ttm) 4.85M
Revenue Per Share (ttm) 0.11
Quarterly Revenue Growth (yoy) -76.90%
Gross Profit (ttm) -6.66M
EBITDA -13.03M
Net Income Avi to Common (ttm) -20.89M
Diluted EPS (ttm) -0.4600

Balance Sheet
Total Cash Per Share (mrq) 0.65 will blow through it and need a serious capital raise imho
Total Debt (mrq) 7.45M
Book Value Per Share (mrq) 0.71

Cash Flow Statement
Operating Cash Flow (ttm) -11.2M
Levered Free Cash Flow (ttm) -5.86M
👍️0
make it happen make it happen 4 년 전
Had R/S a couple years ago and was $0.53 about a year ago
👍️0
make it happen make it happen 4 년 전
Quarterly growth -76.9%, returns are negative, zero profit and cash flow is very negative.

Profitability
Profit Margin 0.00%
Operating Margin (ttm) -300.79%

Management Effectiveness
Return on Assets (ttm) -20.00%
Return on Equity (ttm) -61.68%

Income Statement
Revenue (ttm) 4.85M
Revenue Per Share (ttm) 0.11
Quarterly Revenue Growth (yoy) -76.90%
Gross Profit (ttm) -6.66M
EBITDA -13.03M
Net Income Avi to Common (ttm) -20.89M
Diluted EPS (ttm) -0.4600

Balance Sheet
Total Cash Per Share (mrq) 0.65
Total Debt (mrq) 7.45M
Book Value Per Share (mrq) 0.71

Cash Flow Statement
Operating Cash Flow (ttm) -11.2M
Levered Free Cash Flow (ttm) -5.86M
👍️0
make it happen make it happen 4 년 전
I agree it states that Novartis is in chagre and IMMP is "ELIGIBLE" to receive milestones and payments. Previous reverse split. IMHO prob going to be bled
👍️0
reverse_long reverse_long 4 년 전
IMMP never holds any spikes. Every time it has fastrack or patent news it dumps away. It is the real deal to dump very hard. GLTA!
👍️0
calahan67 calahan67 4 년 전
This is the real deal folks
👍️0
ClayTrader ClayTrader 4 년 전
* * $IMMP Video Chart 03-25-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
DewDiligence DewDiligence 4 년 전
IMMP up on BMY's LAG-3 coattails: #msg-162784750.
👍️0
calahan67 calahan67 4 년 전
And they have a very sharp ceo if you've seen any of their videos he tells it straight up imo
👍️0
calahan67 calahan67 4 년 전
Up huge on no news a great big sleeper imo
👍️0
calahan67 calahan67 4 년 전
Looks like accumulation is beginning a slow churn higher
👍️0
everything everything 4 년 전
Interesting company, looks to be in reversal but dip opportunity may be in the works.
👍️0
akamaii akamaii 4 년 전
Like it here
👍️0
lecorb lecorb 4 년 전
$IMMP: TIPRANKS, SCORE, UPGRADE TO 10 OUTPERFORM! ANALIST RATINGS: PT: $6.50 MODERATE BUY! LOW: @5.50, MED:@6.50, HI: $8.00 Jason McCarthy Maxim Group 5 Stars target $8.00 ranking Buy analystAction Reiterated date 6 days ago Last calification.
👍️0

최근 히스토리

NASDAQ
IMMP
Immutep
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지